Consistency

Velocity Automotive to Share Evolving Dynamics of Appraisal Effectiveness at Digital Dealer Webinar

Retrieved on: 
torsdag, juni 22, 2023
De Young, Future value, Consistency, Accuracy and precision

"In today's fluctuating marketplace, appraisal accuracy has never been so critical.

Key Points: 
  • "In today's fluctuating marketplace, appraisal accuracy has never been so critical.
  • Capturing a higher percentage of trade-in opportunities has tremendous opportunity potential for dealerships, which we must become more diligent about," DeYoung said.
  • In this presentation, Driving Appraisal Success with Precision: Using the Power of Accurate and Transparent Valuations.
  • Managing Expectations – Tools and communications for reducing disappointment or misunderstandings and using open communications to enhance customer satisfaction.

GWM Ranked as BrandZ Top 20 Chinese Global Brand Builders 2023

Retrieved on: 
lördag, juni 17, 2023
Classification, Marketing, Hydrogen, Consistency, Auto Shanghai, Research, Kantar, GWM, Transport, Global Brands Group, Retail

GWM entered the top 20 Chinese Global Brand Builders 2023, rising by 11 positions compared to last year.

Key Points: 
  • GWM entered the top 20 Chinese Global Brand Builders 2023, rising by 11 positions compared to last year.
  • The BrandZ ranking is a globally recognised list of the most valuable brands, compiled by Google and Kantar and published jointly.
  • This global reach enables GWM to enter into diverse consumer markets and obtain access to a diverse customer base.
  • GWM's success on the BrandZ ranking list is evidence of the company's unwavering commitment to excellence and its ability to thrive in the global automotive industry.

Global RFID Tags Industry Research Report 2022-2030: HF RFID Tags to Dominate the Market; UHF RFID Tags Segment to Register the Highest Growth - ResearchAndMarkets.com

Retrieved on: 
fredag, juni 16, 2023
Veterinary, Agriculture, Natural Resources, Health, Technology, Logistics, Supply Chain Management, Transport, Other Technology, Tag, Drive, Target Corporation, RFID, Consistency, RAIN, CPG, HF, Bolloré Transport & Logistics, US, UHF, Projective identification, Nature, Reading, St Dominic, Downham Market, Growth, Metro AG, LF, Warehouse, Speciality chemicals, Marketing

Additionally, major consumer packages goods (CPG) companies too hold prominent position in adopting RFID tracking systems, thereby supporting the RFID tags market growth.

Key Points: 
  • Additionally, major consumer packages goods (CPG) companies too hold prominent position in adopting RFID tracking systems, thereby supporting the RFID tags market growth.
  • HF RFID Tags to Dominate the Market; UHF RFID Tags Segment to Register the Highest Growth
    HF RFID tags segment led the overall market in 2021, contributing to more than 40% of the total market revenue generated worldwide.
  • In the following years, UHF RFID tags segment is set to register the highest growth in the market.
  • Due to continued adoption of UHF RFID (RAIN RFID) systems in the industry, market players are more inclined towards introducing UHF RFID tags.

Cantourage UK Partners with Portocanna to Improve Affordable Medical Cannabis Access in the UK

Retrieved on: 
fredag, juni 16, 2023
Partnership, Way, CBPM, Genetics, Consistency, Channel, Certification, Philosophy, Patient, Cannabis, Quality control, Entrepreneurship, Drug, Pharmaceutical industry, EU

LONDON, June 16, 2023 /PRNewswire/ -- Leading London-based medical cannabis company Cantourage UK and Portugal-based manufacturer Portocanna have announced an exclusive partnership. This collaboration aims to deliver affordable high-quality CBPM's to patients in the UK, fulfilling an important unmet need in the market.

Key Points: 
  • The Partnership Paves the Way for Consistent, High-Quality Affordable Medical Cannabis Supply for Patients
    LONDON, June 16, 2023 /PRNewswire/ -- Leading London-based medical cannabis company Cantourage UK and Portugal-based manufacturer Portocanna have announced an exclusive partnership.
  • Joshua Cuby, Co-Founder & Chief Sales Officer of Cantourage UK stated "In Cantourage UK, our focus has always been on delivering quality, consistent genetics and CBPMs.
  • "We trust Cantourage UK to enable us to fulfil our vision of consistent, reliable access to top-grade medical cannabis products for patients."
  • This collaboration between Cantourage UK and Portocanna will play a pivotal role in shaping the UK's medical cannabis landscape, securing more reliable access to quality medical cannabis for UK patients.

UKG Transforms Multi-country Payroll with Agreement to Acquire Immedis from CluneTech

Retrieved on: 
tisdag, juni 6, 2023
Technology, Human Resources, Finance, Consulting, Professional Services, Software, Asset Management, Data Management, Other Professional Services, Singular, Workforce, Consistency, Multimedia, Organization, UKG, Acquisition, HR, Benchmarking, HCM, Health care, Risk management, Immediate Media Company

View the full release here: https://www.businesswire.com/news/home/20230606005759/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230606005759/en/
    UKG today announced an agreement to acquire Immedis.
  • Developed in close collaboration between UKG and Immedis, One View utilizes the strengths of both organizations to transform the traditionally fragmented global payroll model.
  • “Combining Immedis and UKG ensures that businesses and their employees will have the best possible multicountry payroll experience.
  • “Having worked closely and strategically with Immedis for several years now, we’re thrilled to welcome the entire Immedis team into the UKG family.”

Huawei Cloud Launches Financial Container Cloud to Enable Cloud Native Core Banking

Retrieved on: 
onsdag, juni 7, 2023
Cloud, Maintenance, Infrastructure as a service, Huawei, Speech, IPv6, Persistence (computer science), Consistency, CNCF, Daiwa Securities Group, Agricultural Bank, Platinum, Agricultural Bank of China, APM, BUILD, QOS, Diving, AOM, PSBC, Internet Protocol version 4, Video game, Network equipment provider, Mobile phone, Risk management, Kubernetes, Application

On June 7, William Dong, President of Huawei Cloud Marketing, delivered a keynote speech focusing on industry insights and value propositions and released the innovative solution Financial Container Cloud at the Huawei Global Intelligent Financial Summit.

Key Points: 
  • On June 7, William Dong, President of Huawei Cloud Marketing, delivered a keynote speech focusing on industry insights and value propositions and released the innovative solution Financial Container Cloud at the Huawei Global Intelligent Financial Summit.
  • Hu Yuhai, Vice President of Huawei Cloud Stack, introduced the new solution in detail at the summit:"Underpinned by Huawei Cloud Stack, the Financial Container Cloud is deployed in customers' on-premises data centers.
  • It has four features: high performance, high scalability & security, high maintainability and good openness and compatibility"
    The Financial Container Cloud incorporates Huawei Cloud's latest cloud service, CCE Turbo, delivering stellar performance and profound experience.
  • Moving forward, Huawei Cloud Stack will partner with financial customers to continue embracing container technologies and diving into cloud together for a digital future.

Huawei Cloud Launches Financial Container Cloud to Enable Cloud Native Core Banking

Retrieved on: 
onsdag, juni 7, 2023
Cloud, Maintenance, Infrastructure as a service, Huawei, Speech, IPv6, Persistence (computer science), Consistency, CNCF, Daiwa Securities Group, Agricultural Bank, Platinum, Agricultural Bank of China, Multimedia, APM, BUILD, QOS, Diving, AOM, PSBC, Internet Protocol version 4, Video game, Network equipment provider, Mobile phone, Risk management, Kubernetes, Application

On June 7, William Dong, President of Huawei Cloud Marketing, delivered a keynote speech focusing on industry insights and value propositions and released the innovative solution Financial Container Cloud at the Huawei Global Intelligent Financial Summit.

Key Points: 
  • On June 7, William Dong, President of Huawei Cloud Marketing, delivered a keynote speech focusing on industry insights and value propositions and released the innovative solution Financial Container Cloud at the Huawei Global Intelligent Financial Summit.
  • Hu Yuhai, Vice President of Huawei Cloud Stack, introduced the new solution in detail at the summit:"Underpinned by Huawei Cloud Stack, the Financial Container Cloud is deployed in customers' on-premises data centers.
  • It has four features: high performance, high scalability & security, high maintainability and good openness and compatibility"
    The Financial Container Cloud incorporates Huawei Cloud's latest cloud service, CCE Turbo, delivering stellar performance and profound experience.
  • Moving forward, Huawei Cloud Stack will partner with financial customers to continue embracing container technologies and diving into cloud together for a digital future.

Sutro Biopharma Announces Oral Presentation at ASCO 2023 Featuring Data for Luveltamab Tazevibulin from the Phase 1 Dose-Expansion Study in Ovarian Cancer and the Initiation of the Phase 2/3 Pivotal Study REFRaME-O1

Retrieved on: 
lördag, juni 3, 2023
Vall, Consistency, DOR, ReFrame, Sutro, PFS, TPS, Teaching hospital, ASCO, American Society of Clinical Oncology, Patient, Folate, SAN, STRO, Annual general meeting, ADC, Spacecraft, Ovarian cancer, Society, ORR, Pharmaceutical industry

SOUTH SAN FRANCISCO, Calif., June 03, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that results from a Phase 1 dose-expansion study of luveltamab tazevibulin (luvelta), a novel Folate receptor alpha (FolRα)-targeting ADC, in patients with advanced ovarian cancer were featured in an oral presentation at the 2023 American Society of Clinical Oncology (ASCO 2023) Annual Meeting in Chicago, IL. In parallel, the Company continues to advance the clinical development of luvelta and announced that sites are now open for enrollment in REFRaME-O1, the pivotal Phase 2/3 study for patients with platinum-resistant ovarian cancer.

Key Points: 
  • In parallel, the Company continues to advance the clinical development of luvelta and announced that sites are now open for enrollment in REFRaME-O1, the pivotal Phase 2/3 study for patients with platinum-resistant ovarian cancer.
  • Responses were seen in FolRα expressing patients with TPS >25%, addressing patients who may not be eligible for other approved therapies targeting FolRα.
  • “On the heels of these positive results, we are thrilled that REFRaME, our pivotal Phase 2/3 trial, is officially underway.
  • From the clinical and nonclinical data gathered, we maintain our positive outlook that luvelta could potentially serve multiple additional indications where patients express FolRα.”

Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study

Retrieved on: 
lördag, juni 3, 2023
Oncology, Health, FDA, General Health, Clinical Trials, Pharmaceutical, Biotechnology, Senior, Consistency, Lung cancer, DZ, NSCLC, DCO, PFS, ORR, Arcus, Incidence, Dor, Patient, Safety, Pharmaceutical industry

++Across all arms, one participant in the DZ arm had a response pending confirmation, which was confirmed after DCO date.

Key Points: 
  • ++Across all arms, one participant in the DZ arm had a response pending confirmation, which was confirmed after DCO date.
  • - Consistent ORR and PFS improvements were shown for the domvanalimab-containing arms in a post-hoc analysis of centrally confirmed PD-L1-high patients.
  • The addition of domvanalimab to zimberelimab did not increase the incidence of infusion-related reactions, consistent with the Fc-silent design of domvanalimab.
  • Neither Gilead nor Arcus has received approval from any regulatory authority for any use globally, and their safety and efficacy for the treatment of lung cancer have not been established.

Omega Therapeutics Presents New Preclinical Data Demonstrating the Potential of Omega Epigenomic Controllers™ to Synergize with Immunotherapies at the ASCO 2023 Annual Meeting

Retrieved on: 
onsdag, maj 31, 2023
Combination, MYC, Doctor of Philosophy, Hepatocellular carcinoma, Consistency, OEC, American Society of Clinical Oncology, Clinical trial, Liver tumor, Omega, NSCLC, Lung cancer, Immunotherapy, Messenger, ASCO, Liver, CD8, CBI, Annual general meeting, TME, Regional Security System, Standard of care, Therapy, IND, PD-L1, Tumor microenvironment, HCC, Society, Vaccine, Pharmaceutical industry

“The enhanced anti-tumor activity demonstrated in these preclinical data strongly support further investigation of MYC-targeting OECs in combination with clinically-validated approaches such as checkpoint blockade immunotherapies.

Key Points: 
  • “The enhanced anti-tumor activity demonstrated in these preclinical data strongly support further investigation of MYC-targeting OECs in combination with clinically-validated approaches such as checkpoint blockade immunotherapies.
  • MYC OECs downregulated expression of PD-L1 protein on the surface of HCC and NSCLC tumor cells in vitro.
  • The combination of MYC OEC and anti-PD-1 or anti-PD-L1 blockade significantly reduced tumor growth in a mouse xenograft liver tumor model compared to single agent treatment.
  • In immune-competent mouse allograft tumor models MYC OEC alone or in combination with CBI conferred anti-tumor immune memory.